Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 113 Print this page  Email this page Small font size Default font size Increase font size

  Article Access Statistics

Year : 2020 | Volume:  35 | Issue Number:  4 | Page:  299-304

ORIGINAL ARTICLE

Health-related quality-of-life outcomes with actinium-225-prostate-specific membrane antigen-617 therapy in patients with heavily pretreated metastatic castration-resistant prostate cancer
Satapathy Swayamjeet, Mittal Bhagwant Rai, Sood Ashwani, Das Chandan Krushna, Singh Shrawan Kumar, Mavuduru Ravimohan Suryanarayan, Bora Girdhar Singh

Number of times this article was viewed 826
Number of times this article has been printed  from the site 22
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
 Back To Article

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal